Decreased Threshold of Fasting Serum Glucose for Cardiovascular Events: MASHAD Cohort Study | Zendy

Fatemeh Sadabadi | Zendy; Aida Gholoobi | Zendy; Alireza Heidari-Bakavol | Zendy; Mohsen Mouhebati | Zendy; Ali Javandoost | Zendy; Zahra Asadi | Zendy; Maryam SaberiKarimian | Zendy; Susan Darroudi | Zendy; Mohammad Sadegh Khorrami Mohebbseraj | Zendy; Farzad Rahmani | Zendy; Najmeh Malekzadeh Gonabadi | Zendy; Fatemehalsadat Jafari Sheshtamad | Zendy; Sara Samadi | Zendy; Afsane Bahrami | Zendy; Gordon A. Ferns | Zendy; Majid GhayourMobarhan | Zendy; Habibollah Esmaeili | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Decreased Threshold of Fasting Serum Glucose for Cardiovascular Events: MASHAD Cohort Study

Author(s) -

Fatemeh Sadabadi,

Aida Gholoobi,

Alireza Heidari-Bakavol,

Mohsen Mouhebati,

Ali Javandoost,

Zahra Asadi,

Maryam SaberiKarimian,

Susan Darroudi,

Mohammad Sadegh Khorrami Mohebbseraj,

Farzad Rahmani,

Najmeh Malekzadeh Gonabadi,

Fatemehalsadat Jafari Sheshtamad,

Sara Samadi,

Afsane Bahrami,

Gordon A. Ferns,

Majid GhayourMobarhan,

Habibollah Esmaeili

Publication year - 2020

Publication title -

reports of biochemistry and molecular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.467

H-Index - 8

ISSN - 2322-3480

DOI - 10.29252/rbmb.9.1.64

Subject(s) - dyslipidemia , medicine , lipid profile , diabetes mellitus , impaired fasting glucose , cohort , cut point , population , hazard ratio , receiver operating characteristic , gastroenterology , endocrinology , impaired glucose tolerance , type 2 diabetes , confidence interval , mathematics , statistics , environmental health

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, and specifically in Iran. Generally, diabetes mellitus is the result of impaired glucose tolerance which together with dyslipidemia are considered as important risk factors of CVD. The aim of this study was to determine the relationship between fasting serum glucose (FSG), lipid profile and CVD endpoints, and to establish an optimal FSG cut-off in the MASHAD cohort study after nearly 6 years of follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research